Patents by Inventor Kazuyuki Sugita
Kazuyuki Sugita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20200403226Abstract: The invention discloses a positive electrode active material for a magnesium secondary battery or lithium ion secondary battery, including: a particle including a nucleus and a crystal of vanadium oxide grown from the nucleus as a starting point and having a maximum length of 5 ?m or less in the major axis direction.Type: ApplicationFiled: September 12, 2018Publication date: December 24, 2020Applicant: Sanoh Industrial Co., Ltd.Inventors: Koga-shi, ARAI, Kazuyuki SUGITA, Atsushi HONDA, Yuichiro TAKIMOTO, Hideki KURIHARA, Masashi INAMOTO, Kyousuke DOUMAE
-
Publication number: 20120316342Abstract: This invention provides a therapeutic agent for hepatitis C comprising, as an active ingredient, a compound having anti-HCV activity useful in treatment of hepatitis C. The therapeutic agent for hepatitis C comprises, as an active ingredient, a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: January 31, 2011Publication date: December 13, 2012Inventors: Masanori Baba, Yuichi Hashimoto, Hiroshi Aoyama, Kazuyuki Sugita, Masahiko Nakamura, Atsushi Aoyama, Yasuo Urata
-
Patent number: 8309546Abstract: There is provided a novel compound that inhibits phosphatidylinositol 3-kinase (PI3K) and/or the mammalian target of rapamycin (mTOR) and exhibits anti-tumor activity. The present invention provides a compound represented by the following formula (1) having various substituents that inhibits PI3K and/or mTOR and exhibits anti-tumor activity: wherein R1, R2, R3, R4, Ra, Rb, Rc, and X each have the same meaning as defined in the specification.Type: GrantFiled: November 30, 2011Date of Patent: November 13, 2012Assignee: Daiichi Sankyo Company, LimitedInventors: Kiyoshi Nakayama, Kazuyuki Sugita, Masaki Setoguchi, Yuichi Tominaga, Masanori Saitou, Takashi Odagiri
-
Publication number: 20120071476Abstract: There is provided a novel compound that inhibits phosphatidylinositol 3-kinase (PI3K) and/or the mammalian target of rapamycin (mTOR) and exhibits anti-tumor activity. The present invention provides a compound represented by the following formula (1) having various substituents that inhibits PI3K and/or mTOR and exhibits anti-tumor activity: wherein R1, R2, R3, R4, Ra, Rb, Rc, and X each have the same meaning as defined in the specification.Type: ApplicationFiled: November 30, 2011Publication date: March 22, 2012Applicant: Daiichi Sankyo Company, LimitedInventors: Kiyoshi Nakayama, Kazuyuki Sugita, Masaki Setoguchi, Yuichi Tominaga, Masanori Saitou, Takashi Odagiri
-
Patent number: 8097622Abstract: There is provided a novel compound that inhibits phosphatidylinositol 3-kinase (PI3K) and/or the mammalian target of rapamycin (mTOR) and exhibits anti-tumor activity. The present invention provides a compound represented by the following formula (1) having various substituents that inhibits PI3K and/or mTOR and exhibits anti-tumor activity: wherein R1, R2, R3, R4, Ra, Rb, Rc, and X each have the same meaning as defined in the specification.Type: GrantFiled: October 14, 2009Date of Patent: January 17, 2012Assignee: Daiichi Sankyo Company, LimitedInventors: Kiyoshi Nakayama, Kazuyuki Sugita, Masaki Setoguchi, Yuichi Tominaga, Masanori Saitou, Takashi Odagiri
-
Publication number: 20100130492Abstract: There is provided a novel compound that inhibits phosphatidylinositol 3-kinase (PI3K) and/or the mammalian target of rapamycin (mTOR) and exhibits anti-tumor activity. The present invention provides a compound represented by the following formula (1) having various substituents that inhibits PI3K and/or mTOR and exhibits anti-tumor activity: wherein R1, R2, R3, R4, Ra, Rb, Rc, and X each have the same meaning as defined in the specification.Type: ApplicationFiled: October 14, 2009Publication date: May 27, 2010Applicant: DAIICHI SANKYO COMPANY, LIMITEDInventors: Kiyoshi Nakayama, Kazuyuki Sugita, Masaki Setoguchi, Yuichi Tominaga, Masanori Saitou, Takashi Odagiri
-
Publication number: 20090181942Abstract: The present invention relates to tricyclic compounds each represented by the following formula (I): (wherein, R1, R2, R2?, R3, R4, X, Y and Z have the same meanings as defined in the specification); and a drug containing the compound. Since the compounds according to the present invention exhibit an excellent squalene synthetase inhibitory effect and cholesterol synthesis inhibitory effect so that they are useful as a drug such as preventive and/or remedy for diseases in mammals including humans such as hyperlipemia, e.g., hypercholesterolemia, hypertriglyceridemia, and low HDL cholesterolemia and/or arteriosclerosis.Type: ApplicationFiled: October 23, 2006Publication date: July 16, 2009Applicant: DAIICHI SANKYO COMPANY, LIMITEDInventors: Kazuyuki Sugita, Masami Otsuka, Hitoshi Oki, Noriyasu Haginoya, Masanori Ichikawa, Masao Itoh
-
Patent number: 6448266Abstract: Substituted cyclobutylamine derivativesb with a novel structure represented by the following formula (I), wherein R1 to R4 and Q each represents a specific substituent and, in particular, Q represents a quinolone derivative having a specific structure. These derivatives are useful as antibacterial compounds which have excellent antibacterial activity against a wide scope of bacteria including Gram-negative and Gram-positive bacteria, exert potent antibacterial activity particularly against methicillin-resistant Staphylococcus aureus (MRSA) strains, penicillin-resistant pneumococcus strains and quinolone-resistant bacteria, and are also possessed of both excellent pharmacokinetics and high safety.Type: GrantFiled: November 30, 1999Date of Patent: September 10, 2002Assignee: Daiichi Pharmaceutical Co., Ltd.Inventors: Makoto Takemura, Hisashi Takahashi, Kazuyuki Sugita, Rie Miyauchi
-
Publication number: 20020077345Abstract: Antimicrobial agents being excellent in antimicrobial activity and safety.Type: ApplicationFiled: November 2, 2001Publication date: June 20, 2002Applicant: DAIICHI PHARMACEUTICAL CO., LTD.Inventors: Makoto Takemura, Hisashi Takahashi, Kazuyuki Sugita, Hitoshi Ohki, Satoru Miyauchi, Rie Miyauchi
-
Patent number: 6184388Abstract: An antimicrobial drug having excellent antimicrobial activity and high safety is disclosed, which comprises as an active ingredient, a quinolone derivative having a substituted aminocycloalkylpyrrolidine as a substituent and which is further substituted with various substituents, represented by formula (I), its salts and hydrates thereof: wherein Q is represented by formula (II) or (IV).Type: GrantFiled: September 17, 1999Date of Patent: February 6, 2001Assignee: Daiichi Pharmaceutical Co., Ltd.Inventors: Makoto Takemura, Youichi Kimura, Hisashi Takahashi, Kenichi Kimura, Satoru Miyauchi, Hitoshi Ohki, Kazuyuki Sugita, Rie Miyauchi
-
Patent number: 6121285Abstract: An antimicrobial drug having excellent antimicrobial activity and high safety is disclosed, which comprises as an active ingredient, a quinolone-derivative having a substituted aminocycloalkylpyrrolidine as a substituent and which is further substituted with various substituents, represented by formula (I), its salts and hydrates thereof: ##STR1## wherein Q is represented by formula (II) or (IV). ##STR2## Also disclosed is a quinolone derivative where R.sup.Type: GrantFiled: May 21, 1998Date of Patent: September 19, 2000Assignee: Daiichi Pharmaceutical Co., Ltd.Inventors: Makoto Takemura, Youichi Kimura, Hisashi Takahashi, Kenichi Kimura, Satoru Miyauchi, Hitoshi Ohki, Kazuyuki Sugita, Rie Miyauchi
-
Patent number: 5705304Abstract: Electrophotographic toners comprising a resin, a colorant, a charge controlling agent and an offset preventing agent. The resin comprises a copolymer containing at least one of phenyl isopropenyl ketone and its derivatives as a constituting monomer. The copolymer is photodegradable and thus the toners can be are used for recycling paper.Type: GrantFiled: July 20, 1995Date of Patent: January 6, 1998Assignees: Toyo Ink Manufacturing Co., Ltd., Kazuyuki SigitaInventors: Kazuyuki Sugita, Ken-ichi Kishi, Hirofumi Iemura
-
Patent number: 5559224Abstract: Carbapenem derivatives which may be utilized as antibiotics and which show strong antibacterial activity against various bacterial strains including Pseudomonas aeruginosa. The compounds containing the derivatives are quite safe and are also stable against hydrolases such as dehyropeptidase (DHP).Type: GrantFiled: May 5, 1995Date of Patent: September 24, 1996Assignee: Daiichi Pharmaceutical Co., Ltd.Inventors: Toshiyuki Nishi, Hiroko Koda, Kazuyuki Sugita, Yohhei Ishida, Makoto Takemura, Takeshi Hayano